Investigational Treatment of Depressive Disorders With Neuroactive Steroids: Potential Implications for Premenstrual Dysphoric Disorder

J Clin Psychiatry. 2021 Jun 8;82(4):20ac13853. doi: 10.4088/JCP.20ac13853.

Authors

Mercedes J Szpunar^{1

2}, Marlene P Freeman¹

Affiliations

¹ Ammon-Pinizzotto Center for Women's Mental Health, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
² Corresponding author: Mercedes J. Szpunar, MD, PhD, Ammon-Pinizzotto Center for Women's Mental Health, Department of Psychiatry, Massachusetts General Hospital, 185 Cambridge St, Suite 2200, Boston, MA 02114 (mszpunar@mgh.harvard.edu).

PMID: 34106531
DOI: 10.4088/JCP.20ac13853

No abstract available

Publication types

Research Support, U.S. Gov't, Non-P.H.S.
Review

MeSH terms

Female
Humans
Luteal Phase / drug effects
Neurosteroids / pharmacology
Neurosteroids / therapeutic use*
Premenstrual Dysphoric Disorder / drug therapy*

Substances

Neurosteroids